Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinomaRoniel Cabrera, David R. Nelson, Todd M. Brusko et al.|Cancer Immunology Immunotherapy|2012Cited by 108
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsHans K. Ghayee, Fernando Bril, Heather Hatch et al.|Metabolism|2020Cited by 22